Sponsor

Alcon Research

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Alcon Research appears in 176 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials176
Recruiting shown1
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
Hydrus® Microstent New Enrollment Post-Approval StudyNCT04553523 · lead sponsor · 2020-08-25
RECRUITING
Reformulated PG324 Ophthalmic Solution for Intraocular Pressure ReductionNCT07082816 · lead sponsor · 2025-09-02
COMPLETED
Next Generation RocklatanNCT06441643 · lead sponsor · 2024-09-04
COMPLETED
EX-PRESS® P-50 and EX-PRESS® P-200NCT06119178 · lead sponsor · 2023-11-21
COMPLETED
AONDA Therapeutic Indication Study INCT05891106 · lead sponsor · 2023-06-28
COMPLETED
Safety and Effectiveness of the Hydrus MicrostentNCT05198297 · lead sponsor · 2021-12-13
TERMINATED
Additional Long-Term Follow-up for Subjects Implanted With a CyPass® Micro-StentNCT04629521 · lead sponsor · 2020-12-21
COMPLETED
Post Approval Study of the CyPass SystemNCT03273907 · lead sponsor · 2017-10-12
TERMINATED
Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®NCT02730871 · lead sponsor · 2016-06-24
TERMINATED
24-hr Intraocular Pressure Control With SIMBRINZA ®NCT02770248 · lead sponsor · 2016-05-23
COMPLETED
A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS TrialNCT02700984 · lead sponsor · 2016-03-30
COMPLETED
A Three Part Study of MGV354 in Ocular Hypertension or GlaucomaNCT02743780 · lead sponsor · 2016-03-02
COMPLETED
SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)NCT02419508 · lead sponsor · 2015-08-07
COMPLETED
Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)NCT02339584 · lead sponsor · 2015-04-14
COMPLETED
6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular HypertensionNCT02140060 · lead sponsor · 2014-06-01
COMPLETED
Alcon® Ex-PRESS® Glaucoma Filtration Device in Japanese PatientsNCT02246777 · lead sponsor · 2014-02-26
COMPLETED
Efficacy of Travoprost/Timolol for Uncontrolled Intraocular PressureNCT02003391 · lead sponsor · 2013-12-01
COMPLETED
Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin AnalogueNCT01937312 · lead sponsor · 2013-10-01
COMPLETED
Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®NCT01937299 · lead sponsor · 2013-10-01
COMPLETED
Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular HypertensionNCT01978600 · lead sponsor · 2013-10-01
COMPLETED
Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension GlaucomaNCT01995136 · lead sponsor · 2013-09-01
COMPLETED
Nepafenac Once Daily for Macular Edema - Study 1NCT01853072 · lead sponsor · 2013-06-01
COMPLETED
Nepafenac Once Daily for Macular Edema - Study 2NCT01872611 · lead sponsor · 2013-06-01
COMPLETED
Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in RussiaNCT01696383 · lead sponsor · 2013-02-01
WITHDRAWN
Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma PatientsNCT01658839 · lead sponsor · 2013-01-01
COMPLETED
An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®NCT01664039 · lead sponsor · 2012-09-01
COMPLETED
Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma PatientsNCT01652664 · lead sponsor · 2012-09-01
COMPLETED
Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior TherapyNCT01514721 · lead sponsor · 2012-06-01
TERMINATED
Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in BrazilNCT01514734 · lead sponsor · 2012-03-01
TERMINATED
Efficacy of Changing to TRAVATAN® From Prior TherapyNCT01510145 · lead sponsor · 2012-02-01
COMPLETED
Travacom Post Marketing Surveillance StudyNCT01510132 · lead sponsor · 2012-01-01
WITHDRAWN
Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin AmericaNCT01518244 · lead sponsor · 2011-12-01
COMPLETED
Efficacy of Changing to TRAVATAN® From Prior TherapyNCT01493427 · lead sponsor · 2011-12-01
COMPLETED
Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%NCT01452009 · lead sponsor · 2011-11-01
WITHDRAWN
Travoprost 3-Month Safety and Efficacy StudyNCT01453855 · lead sponsor · 2011-11-01
COMPLETED
Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)NCT01464424 · lead sponsor · 2011-10-01
COMPLETED
Patient Preference Comparison of AZARGA Versus COSOPTNCT01340014 · lead sponsor · 2011-09-01
COMPLETED
Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in CanadaNCT01415401 · lead sponsor · 2011-09-01
COMPLETED
A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%NCT01426867 · lead sponsor · 2011-09-01
COMPLETED
Efficacy of Changing to DUOTRAV® From Prior TherapyNCT01327599 · lead sponsor · 2011-08-01
COMPLETED
Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412CNCT01312454 · lead sponsor · 2011-06-01
TERMINATED
AL-54478 Proof of Concept StudyNCT01318252 · lead sponsor · 2011-06-01
COMPLETED
Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular HypertensionNCT01309204 · lead sponsor · 2011-05-01
COMPLETED
Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular HypertensionNCT01310777 · lead sponsor · 2011-05-01
COMPLETED
AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular PressureNCT01484951 · lead sponsor · 2011-05-01
COMPLETED
Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin TherapyNCT01263444 · lead sponsor · 2011-03-01
COMPLETED
Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%NCT01297920 · lead sponsor · 2011-03-01
COMPLETED
Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on TimololNCT01336569 · lead sponsor · 2011-02-01
COMPLETED
Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%NCT01297517 · lead sponsor · 2011-02-01
COMPLETED
Divided Dose of TRAVATAN®NCT01298687 · lead sponsor · 2011-02-01
COMPLETED
Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular HypertensionNCT01357616 · lead sponsor · 2010-11-01
COMPLETED
Safety and Efficacy of Changing to DuoTrav From Prior TherapyNCT01230736 · lead sponsor · 2010-10-01
COMPLETED
Patient Preference Comparison of AZARGA Versus COSOPT in Patients With GlaucomaNCT01471158 · lead sponsor · 2010-09-01
COMPLETED
To Assess the Safety and Efficacy of Travacom in Patients With Uncontrolled Intraocular PressureNCT01159756 · lead sponsor · 2010-07-01
COMPLETED
Travoprost Five Day Posology StudyNCT01114893 · lead sponsor · 2010-04-01
COMPLETED
Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular HypertensionNCT01111890 · lead sponsor · 2010-04-01
COMPLETED
DuoTrav APS Versus XALACOM® in Ocular Surface HealthNCT00912054 · lead sponsor · 2010-03-01
TERMINATED
ELAZOP Switching Study in KoreaNCT01055366 · lead sponsor · 2010-03-01
COMPLETED
Evaluation of FID 114657 in Sjogren's Syndrome SubjectsNCT01079871 · lead sponsor · 2010-02-01
COMPLETED
Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular HypertensionNCT00872651 · lead sponsor · 2010-01-01
COMPLETED

Sponsor roles

lead sponsor142
collaborator34
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.